Marie-Paule Sablin

ScholarGPS® ID: 94395108730532

Affiliation

Institut Curie, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

3,415

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis (journal article) Vasseur, Antoine \| Cabel, Luc \| Hego, Caroline \| Takka, Wissam \| Trabelsi Grati, Olfa \| Renouf, Benjamin \| Lerebours, Florence \| Loirat, Delphine \| Brain, Etienne \| Cottu, Paul \| ... \| Bidard, François-Clément Oncogene, volume 43, issue 16, pages 1214-1222 (2024). 10.1038/s41388-024-02986-6 Cite \| Source
Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer (journal article) Basse, Clémence \| Ancel, Julien \| Massiani, Marie-Ange \| Bonté, Pierre-Emmanuel \| Beaulaton, Clément \| Beaucaire-Danel, Sophie \| Milder, Maud \| Cao, Kim \| Daniel, Catherine \| Du Rusquec, Pauline \| ... \| Girard, Nicolas Lung Cancer, volume 182 (2023). 10.1016/j.lungcan.2023.107295 Cite \| Source
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation (journal article) Patsouris, Anne \| Diop, Kadija \| Tredan, Olivier \| Nenciu, Daniel \| Gonçalves, Anthony \| Arnedos, Monica \| Sablin, Marie-Paule \| Jézéquel, Pascal \| Jimenez, Marta \| Droin, Nathalie \| ... \| André, Fabrice European Journal of Cancer, volume 159 (2021). 10.1016/j.ejca.2021.09.028 Cited by (27) \| Cite \| Source
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy (journal article) Vaflard, Pauline \| Paoletti, Xavier \| Servois, Vincent \| Tresca, Patricia \| Pons-Tostivint, Elvire \| Sablin, Marie-Paule \| Ricci, Francesco \| Loirat, Delphine \| Hescot, Ségolène \| Torossian, Nouritza \| ... \| Le Tourneau, Christophe Drugs in R&D, volume 21, issue 4, pages 399-406 (2021). 10.1007/s40268-021-00362-3 Cited by (8) \| Cite \| Source
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer (journal article) Schmid, Peter \| Sablin, Marie-Paule \| Bergh, Jonas \| Im, Seock-Ah \| Lu, Yen-Shen \| Martínez, Noelia \| Neven, Patrick \| Lee, Keun Seok \| Morales, Serafín \| Pérez-Fidalgo, J. Alejandro \| ... \| Cortés, Javier Breast Cancer Research, volume 23, issue 1 (2021). 10.1186/s13058-020-01382-8 Cited by (15) \| Cite \| Source
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT) (journal article) Marret, Grégoire \| Bièche, Ivan \| Dupain, Célia \| Borcoman, Edith \| du Rusquec, Pauline \| Ricci, Francesco \| Hescot, Ségolène \| Sablin, Marie-Paule \| Tresca, Patricia \| Bello, Diana \| ... \| Kamal, Maud JCO Precision Oncology (2021). 10.1200/PO.20.00280 Cited by (26) \| Cite \| Source
75P Tumor mutational burden in clinical routine practice: Identifying the right threshold? (journal article) Dupain, C. \| Gutman, T. \| Girard, E. \| du Rusquec, P. \| Sablin, M-P. \| Tresca, P. \| Neuzillet, C. \| Vincent-Salomon, A. \| Antonio, S. \| Franck, C. \| ... \| Masliah-Planchon, J. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.355 Cite \| Source
A phase Ib study of xentuzumab plus abemaciclib and fulvestrant in patients (pts) with advanced hormone receptor-positive (HR+), HER2-negative breast cancer (BC) with visceral or non-visceral disease. (journal article) Yee, Douglas \| LoRusso, Patricia \| Sablin, Marie Paule \| Prat, Aleix \| Stradella, Agostina \| Utriainen, Meri \| Oliveira, Mafalda \| Yonemori, Kan \| Naito, Yoichi \| Hardebeck, Molly Catherine \| ... \| Iwata, Hiroji Journal of Clinical Oncology, volume 39, issue 15_suppl, pages 1057-1057 (2021). 10.1200/JCO.2021.39.15_suppl.1057 Cited by (1) \| Cite \| Source
RADIOPARP: A Phase I of Olaparib with Radiation Therapy (RT) in Patients with Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient with Operated TNBC with Residual Disease (journal article) Kirova, Y. \| Loirat, D. \| Berger, F. \| Ricci, F. \| Sablin, M.P. \| Vincent-Salomon, A. \| Laki, F. \| Mosseri, V. \| Ezzalfani, M. \| Fourquet, A. International Journal of Radiation OncologyBiologyPhysics, volume 108, issue 3, pages S26- (2020). 10.1016/j.ijrobp.2020.07.2117 Cite \| Source
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer (journal article) Smyth, Lillian M. \| Tamura, Kenji \| Oliveira, Mafalda \| Ciruelos, Eva M. \| Mayer, Ingrid A. \| Sablin, Marie-Paule \| Biganzoli, Laura \| Ambrose, Helen J. \| Ashton, Jack \| Barnicle, Alan \| ... \| Hyman, David M. Clinical Cancer Research, volume 26, issue 15, pages 3947-3957 (2020). 10.1158/1078-0432.CCR-19-3953 Cited by (56) \| Cite \| Source
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study (journal article) Heudel, Pierre \| Delaloge, Suzette \| Parent, Damien \| Madranges, Nicolas \| Levy, Christelle \| Dalenc, Florence \| Brain, Etienne \| Uwer, Lionel \| D'HONDT, Veronique \| Augereau, Paule \| ... \| Perol, David Anticancer Research, volume 40, issue 7, pages 3905-3913 (2020). 10.21873/anticanres.14381 Cited by (5) \| Cite \| Source
Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (Atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (aTNBC) (conference) Schmid, P \| Kümmel, S \| Loirat, D \| Savas, P \| Espinosa, E \| Boni, V \| Italiano, A \| White, S \| Singel, S \| Withana, N \| ... \| Sablin, M 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V. (2020) Congress Center München 10.1055/s-0040-1714585 Cited by (3) \| Cite \| Source
CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck (journal article) Billard-Sandu, Camelia \| Tao, Yun-Gan \| Sablin, Marie-Paule \| Dumitrescu, Gabriela \| Billard, David \| Deutsch, Eric European Archives of Oto-Rhino-Laryngology, volume 277, issue 5, pages 1273-1280 (2020). 10.1007/s00405-020-05891-2 Cited by (28) \| Cite \| Source
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients (journal article) Rosenbaum, Pierre \| Artaud, Cécile \| Bay, Sylvie \| Ganneau, Christelle \| Campone, Mario \| Delaloge, Suzette \| Gourmelon, Carole \| Loirat, Delphine \| Medioni, Jacques \| Pein, François \| ... \| Leclerc, Claude Cancer Immunology, Immunotherapy, volume 69, issue 5, pages 703-716 (2020). 10.1007/s00262-020-02503-0 Cited by (31) \| Cite \| Source
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071 (journal article) Piperno-Neumann, Sophie \| Larkin, James \| Carvajal, Richard D. \| Luke, Jason J. \| Schwartz, Gary K. \| Hodi, F. Stephen \| Sablin, Marie-Paule \| Shoushtari, Alexander N. \| Szpakowski, Sebastian \| Chowdhury, Niladri Roy \| ... \| Kapiteijn, Ellen Molecular Cancer Therapeutics, volume 19, issue 4, pages 1031-1039 (2020). 10.1158/1535-7163.MCT-19-0098 Cited by (42) \| Cite \| Source
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer (journal article) Mosele, F. \| Stefanovska, B. \| Lusque, A. \| Tran Dien, A. \| Garberis, I. \| Droin, N. \| Le Tourneau, C. \| Sablin, M.-P. \| Lacroix, L. \| Enrico, D. \| ... \| André, F. Annals of Oncology, volume 31, issue 3, pages 377-386 (2020). 10.1016/j.annonc.2019.11.006 Cited by (170) \| Cite \| Source
Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials (journal article) Pons-Tostivint, Elvire \| Latouche, Aurélien \| Vaflard, Pauline \| Ricci, Francesco \| Loirat, Delphine \| Hescot, Ségolène \| Sablin, Marie-Paule \| Rouzier, Roman \| Kamal, Maud \| Morel, Claire \| ... \| Le Tourneau, Christophe JCO Precision Oncology (2019). 10.1200/PO.18.00114 Cited by (47) \| Cite \| Source
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial (journal article) Jacot, William \| Cottu, Paul \| Berger, Frederique \| Dubot, Coraline \| Venat-Bouvet, Laurence \| Lortholary, Alain \| Bourgeois, Hugues \| Bollet, Marc \| Servent, Veronique \| Luporsi, Elisabeth \| ... \| Bidard, Francois-Clement Breast Cancer Research, volume 21, issue 1 (2019). 10.1186/s13058-019-1215-z Cited by (45) \| Cite \| Source
Detection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers (journal article) Mosele, F. \| Lusque, A. \| Tran Dien, A. \| Droin, N. \| Le Tourneau, C. \| Sablin, M.P. \| Lacroix, L. \| Miran, I. \| Jovelet, C. \| Bieche, I. \| ... \| André, F. Annals of Oncology, volume 30 (2019). 10.1093/annonc/mdz413.096 Cite \| Source
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets (journal article) Moreira, A. \| Masliah-Planchon, J. \| Callens, C. \| Vacher, S. \| Lecerf, C. \| Frelaut, M. \| Borcoman, E. \| Torossian, N. \| Ricci, F. \| Hescot, S. \| ... \| Kamal, M. European Journal of Cancer, volume 121 (2019). 10.1016/j.ejca.2019.09.001 Cited by (12) \| Cite \| Source